A staff nurse is teaching a client who has secondary hypothyroidism about the disease process. The client asks the nurse what causes secondary hypothyroidism. Which of the following responses should the nurse make?

A. Increased energy levels are a common and positive sign of therapeutic response to levothyroxine. Hypothyroidism often leads to fatigue and low energy. When levothyroxine is effective, it helps normalize thyroid hormone levels, which can lead to improved energy levels and a reduction in symptoms like fatigue and lethargy.
B. An increase in weight is not a desired outcome of levothyroxine therapy. In hypothyroidism, weight gain is a common symptom due to slowed metabolism. Successful levothyroxine treatment should help stabilize or reduce weight if it was previously increased due to hypothyroidism. An increase in weight could indicate that the dose of levothyroxine needs adjustment or that other factors are influencing the patient's weight.
C. A decrease in the level of thyroxine (T4) would not typically indicate a therapeutic response to levothyroxine. In fact, the goal of treatment is to normalize T4 levels, so they should be within the normal reference range. An adequate dose of levothyroxine should result in normal or near-normal T4 levels, not a decrease below the normal range.
D. A reduction in appetite is not a common or specific indicator of a therapeutic response to levothyroxine. While levothyroxine can help normalize metabolism and other symptoms of hypothyroidism, a reduction in appetite is not a typical outcome of effective therapy. Appetite changes are not usually used to gauge the effectiveness of thyroid hormone replacement.

A. Chemotherapy often requires multiple infusions over a long period, and a CVAD provides a reliable and convenient access point for these treatments. It allows for the continuous or intermittent administration of chemotherapy drugs, which are often irritating to veins and require precise dosing.
B. While CVADs are used for administering chemotherapy and other treatments, they are not typically used to implant radioactive material for internal radiation (brachytherapy).
C. While CVADs reduce the need for repeated venipunctures and can help manage the complications of frequent injections, they do not eliminate the risk of infection. CVADs can themselves become a source of infection if not properly maintained, as they are open to the external environment.
D. The placement of a CVAD does not directly affect the side effects of chemotherapy, such as nausea and vomiting. The CVAD’s role is primarily related to the administration of medications and access to blood vessels.